jcp From-the-Field

From The Field

From the Field

Bridging the Gap Between Oncologists and Payers: Impact of an EHR-Embedded CDS Tool in Oncology Clinical Pathway (OCP) Adherence

08/15/2024

Anna Bolha , MPAS, PA;

Rebecca Maniago , PharmD, BCOP;

Nina Sardesh ;

Taylor Dias-Foundas ;

James Roose , MA;

Colin Harvey ;

Marcello Ricottone ;

Eric Weber ;

Susan Sabo-Wagner , MSN, RN, OCN, NEA-BC;

Brian Patrick Mulherin , MD;

Andrew Hertler , MD, FACP;

James Hamrick , MD, MPH;

In this report, researchers discuss a real-world study of treatment selection patterns across American Oncology Network medical oncologists, which analyzed pathway adherence rates before and after a pilot project where Evolent level 1...

In this report, researchers...

08/15/2024

Journal of Clinical Pathways

From the Field

Shifting the Paradigm: The Impact of AI at the Point of Care in Cancer Treatment

06/03/2024

Taylor Dias-Foundas ;

This report explores the transformative impact of artificial intelligence (AI) in health care, emphasizing its potential paradigm shift and current deployment in oncology.

This report explores the...

06/03/2024

Journal of Clinical Pathways

From the Field

Bringing Value to Health Care

06/03/2024

Lili Brillstein , MPH;

This paper provides insights and perspective from each constituent involved in shaping health care payment and delivery throughout the US.

This paper provides insights and...

06/03/2024

Journal of Clinical Pathways

From the Field

Comprehensive Genomic Testing: Tissue Stewardship and Best Practices

02/12/2024

Mary Nesline , MS;

Heidi Ko , DO;

Jeffrey M. Conroy , BS;

Maureen E. Cooper , BS;

Shakti H. Ramkissoon , MD, PhD;

Faezeh Koohestani , PhD;

Durga Prasad Dash , PhD;

Brian Caveney , MD, JD, MPH;

Shengle Zhang , MD;

Eric Severson , MD, PhD;

Michelle F. Green , PhD;

Zachary Wallen , PhD;

Sarabjot Pabla , PhD;

Marcia Eisenberg , PhD;

Kyle C. Strickland , MD;

Stephanie Hastings , PhD;

Rebecca A. Previs , MD, MS;

Rebecca A. Previs, MD, et al provide an overview of current genomic testing methodologies and offer guidelines on best practices for tissue stewardship and preanalytic practices for successful comprehensive genomic profiling.

Rebecca A. Previs, MD, et al...

02/12/2024

Journal of Clinical Pathways

From the Field

Real-world Utilization of Second-line Poly (ADP-Ribose) Polymerase Inhibitor Maintenance Therapy Versus Active Surveillance in Community Oncology Practice Patients With Advanced Ovarian Cancer

05/19/2022

Junxin Shi , PhD;

Yiqiong Xie , PhD, MPH;

Katrine L. Wallace , PhD;

Robert Reid , MD;

Dr Wallace and colleagues analyzed second-line poly(ADP-ribose) polymerase inhibitor (PARPi) maintenance therapy in a real-world setting to understand how it is being utilized and the resultant impact on patients’ disease course.

Dr Wallace and colleagues...

05/19/2022

Journal of Clinical Pathways

From the Field

Real-World Characteristics and Outcomes of Patients With Indolent Non-Hodgkin Lymphoma or Mantle Cell Lymphoma Treated With First-Line Bendamustine + Rituximab

04/20/2022

Erica DiMaria , MD;

David Susman ;

Derek Nay , MD;

Rouslan Kotchetkov , MD, PhD;

Lauren Gerard , MD;

Dr Kotchetkov and colleagues assessed the pattern of B-R administration, efficacy and safety in adult patients with indolent non-Hodgkin lymphoma and mantle cell lymphoma with advanced disease and co-morbidities in the real-world setting.

Dr Kotchetkov and colleagues...

04/20/2022

Journal of Clinical Pathways

From the Field

Incidence and Cost of Radical Prostatectomy and Radiotherapy for NCCN Low-risk Prostate Cancer in Utah

03/16/2022

Bryan Crawford ;

Jesse Gygi ;

Brandon Barney , MD;

Libby Petersen ;

McKenzie Bell ;

Zoya Sandhu ;

David Gill , MD;

Jonathan Tward , MD;

Jessica Baumgartner ;

David Gill, MD , and colleagues analyzed rates of treatment for men with low-risk disease who were treated at either The Huntsman Cancer Institute or Intermountain Healthcare facilities, and modeled the costs associated with the presumptive...

David Gill, MD , and colleagues...

03/16/2022

Journal of Clinical Pathways

From the Field

Streamlining Institutional Pathway Processes: The Development and Implementation of a Pathology Molecular Consult to Facilitate Convenient and Efficient Ordering, Fulfillment, and Reporting for Tissue Molecular Tests

02/15/2022

Sharad Mathur , MD;

Janet Barrett ;

Michael Goodman , MD;

Maryam Abdo , MBChB;

Susie Willis ;

Linda Verkruyse , MD;

Joseph Modzelewski ;

Robert Hoyt , MD;

Hanan Elsarraj , MD;

Daniel Mettman , MD;

Daniel Mettman, MD, and colleagues detail the work of two mid-sized VA medical centers in collectively developing and implementing a consult process as part of their oncology clinical pathways to standardize ordering, fulfillment, and...

Daniel Mettman, MD, and...

02/15/2022

Journal of Clinical Pathways

From the Field

Referral Patterns and Treatment Preferences in Patients With Advanced Prostate Cancer: Differences Between Medical Oncologists and Urologists

10/20/2021

Skyler Hime Rupard , MS;

Ajeet Gajra , MD, FACP;

Yolaine J. Jeune-Smith , PhD;

Bruce A. Feinberg , DO;

Ajeet Gajra, MD, FACP, et al assessed the differences between medical oncologists and urologists regarding perceptions on timing of referral and treatment sequence decisions for patients with advanced prostate cancer

Ajeet Gajra, MD, FACP, et al...

10/20/2021

Journal of Clinical Pathways

From the Field

Anticipated Cost Savings with Alternate Dosing Schema of Nivolumab/Ipilimumab for the Treatment of Metastatic Melanoma

08/20/2021

Laura Alwan , PharmD;

Evan Hall , MD;

Kate Trieselmann , PharmD;

Allison Kupsh , PharmD;

Eve Segal , PharmD;

Allison Kupsh, PharmD, and colleagues found that the anticipated cost of NIVO3+IPI1 for the treatment of metastatic melanoma may be lower compared when compared with NIVO1+IPI3, amounting to over $1,000,000 in total savings.

Allison Kupsh, PharmD, and...

08/20/2021

Journal of Clinical Pathways

Current Issue

October 2024

Volume 10

Issue 5

Current Issue

Issue Archive

Special Reports

Sponsored

JCP Special Report

The Value of Tissue-Based Genomic Profiling in Oncology

09/17/2024

Innovations in precision oncology have helped healthcare providers to create more personalized treatment plans and improve patient outcomes. View this special report to learn more.

Innovations in precision...

09/17/2024

Journal of Clinical Pathways

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee ;

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Robin T. Zon , MD, FACP, FASCO;

Gordon Kuntz ;

Winston Wong , PharmD;

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan ;

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

From The Field

Current Issue

Special Reports

Subscribe

Specialties

Events

Year Round Education

HMP Global Products